美鼎生物(VIVO)

33.97+0.000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
美鼎生物
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.meridianbioscience.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Meridian Bioscience, Inc.于1976年在俄亥俄州成立。Meridian是一家完全整合的生命科学公司，主要业务是：（i）开发、制造、销售和分销诊断检测试剂盒，主要用于某些胃肠道和呼吸道传染病以及血铅水平升高；以及（ii）制造和分销体抗原、抗体，体外诊断（“IVD”）制造商和研究人员在人类、动物、植物和环境应用的免疫学和分子试验中使用的PCR/qPCR试剂、核苷酸和生物搜索试剂。
- 2023-02-09
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
- 2023-02-09
  季度报告
  10-Q - Quarterly report [Sections 13 or 15(d)]
  10-Q - Quarterly report [Sections 13 or 15(d)]
- 2023-02-03
  超过5%披露
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-02-02
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

分时
5日
日
周
月

数据加载中...

最高

33.97

今开

33.97

量比

0.00

最低

33.97

昨收

33.97

换手率

0.00%

美鼎生物(VIVO)

公司概况

热议股票